跳至主要内容
临床试验/EUCTR2012-005480-28-ES
EUCTR2012-005480-28-ES进行中(未招募)1 期

Effectiveness of adaptation of the dose of iron supplementation in pregnancy on maternal-child health. Randomized clinical trial (ECLIPSES) - ECLIPSES

Institut d?Investigació en Atenció Primaria IDIAP Jordi Gol0 个研究点开始时间: 2013年4月9日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • ? adult woman
  • ? ICS belonging to
  • ? pregnant less than 12 weeks gestation
  • ? to understand the Castilian or Catalan
  • ? sign the informed consent
  • ? without anemia (Hb <110 d / dL) in the pre-analytical at 12 weeks
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 878
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ? Multiple or risk pregnancy.
  • ? Taking iron supplements containing 10mg iron than in the previous three months
  • ? Pregnant women with hypersensitivity to the active substance, hypersensitivity to egg proteins or intolerant to fructose or galactose.
  • ? chronic or severe pre-existing disease that affects the nutritional development, such as cancer, diabetes mellitus and other metabolic diseases, malabsorptive diseases such as Crohn's disease, ulcerative colitis, gastro-duodenal ulcers, and liver diseases such as chronic hepatitis, liver cirrhosis and chronic pancreatitis.
  • ? Immunosuppression: chronic HIV infection, transplant, neutropenic, or patients receiving immunosuppressive therapy.

研究者

发起方
Institut d?Investigació en Atenció Primaria IDIAP Jordi Gol

相似试验